IMC Chicago’s Nutrien NTR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$7.12M Sell
113,109
-5,500
-5% -$385K ﹤0.01% 1815
2026
Q1
$8.95M Buy
118,609
+86,384
+268% +$6.16M ﹤0.01% 1359
2025
Q4
$1.99M Buy
+32,225
New +$1.9M ﹤0.01% 2433
2025
Q1
– Sell
-45,648
Closed -$2.34M – 3359
2024
Q4
$2.04M Buy
45,648
+30,145
+194% +$1.43M ﹤0.01% 1858
2024
Q3
$745K Buy
+15,503
New +$747K ﹤0.01% 2202
2023
Q4
– Sell
-20,317
Closed -$1.15M – 1896
2023
Q3
$1.25M Buy
+20,317
New +$1.29M ﹤0.01% 1143

Other funds holding NTR

IMC Chicago's NTR Position: Q2 2026 in Review

IMC Chicago reduced its Nutrien (NTR) stake by 4.6% in Q2 2026, selling an estimated $385K and leaving 113,109 shares worth $7.12M. The position accounts for ﹤0.01% of the portfolio, ranked #1815.

IMC Chicago first reported a position in NTR in Q3 2023 and has held it in 6 quarters since. The position peaked at $8.95M in Q1 2026. 734 funds tracked by Wall St. Rank hold NTR as of Q2 2026.

  • IMC Chicago held 113,109 shares of Nutrien worth $7.12M as of Q2 2026.
  • IMC Chicago sold 5,500 Nutrien shares in Q2 2026, an estimated $385K.
  • Nutrien made up ﹤0.01% of IMC Chicago's portfolio in Q2 2026, its #1815 holding.
  • IMC Chicago first reported a position in Nutrien in Q3 2023 and has held it in 6 quarters since.
  • IMC Chicago's Nutrien position peaked at $8.95M in Q1 2026.
  • 734 funds tracked by Wall St. Rank held Nutrien as of Q2 2026.

Based on IMC Chicago's 13F filing for Q2 2026, filed 6 Aug 2026.